<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is a disease of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism that commonly involves multiple comorbidities, including <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:e sem="disease" ids="C0334044" disease_type="Neoplastic Process" abbrv="">dyscrasias</z:e> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Each concurrent disorder contributes some risk of complications and requires therapeutic intervention </plain></SENT>
<SENT sid="2" pm="."><plain>The simultaneous management of so many coexisting illnesses can be complex and commonly results in patients being prescribed multiple medications--referred to as polypharmacy--which may further complicate treatment </plain></SENT>
<SENT sid="3" pm="."><plain>To ensure the best patient outcomes, the treating physician must be aware of <z:hpo ids='HP_0000001'>all</z:hpo> the therapeutic agents that a patient is taking to assess possible drug interactions that such a <z:hpo ids='HP_0001050'>plethora</z:hpo> of medications may confer </plain></SENT>
<SENT sid="4" pm="."><plain>This article addresses the underlying comorbidites, the drugs commonly used to treat them and the interactions that may arise from concomitant administration </plain></SENT>
</text></document>